Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Minoxidil use increases facial hair growth in females, more in older users.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

New treatments for PCOS focus on managing symptoms and improving fertility.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The document explains hair growth, hair loss types, and other hair-related terms.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.